35 results
6-K
EX-99.1
THTX
Theratechnologies Inc.
21 Feb 24
Theratechnologies Reports Financial Results
8:00am
of $3,730,000 related to sudocetaxel zendusortide material and expenses of $536,000 related to the production of bacteriostatic water for injection (“BWFI
6-K
EX-99.1
THTX
Theratechnologies Inc.
26 Sep 23
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
8:02am
of bacteriostatic water for injection (“BWFI”). Excluding these expenses, R&D expenses are down significantly in the three- and nine-month periods of 2023
6-K
EX-99.2
THTX
Theratechnologies Inc.
26 Sep 23
Interim Consolidated Financial Statements
8:00am
water for injection (“BWFI”). Excluding these expenses, R&D expenses are down significantly in the three- and nine-month periods of 2023 compared
6-K
EX-99.2
THTX
Theratechnologies Inc.
12 Jul 23
Interim Consolidated Financial Statements
8:02am
addressing the shortage of bacteriostatic water for injection (“BWFI”) by placing the sourcing of this drug component under our own control via the services
6-K
EX-99.2
7gdx4 qok
12 Apr 23
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.2
fyqs qvlufaovkxv
13 Oct 22
Interim Consolidated Financial Statements
8:01am
6-K
EX-99.1
9rx6ztnzavn
13 Oct 22
Theratechnologies Reports Financial Results
7:45am
6-K
EX-99.2
e8u0tq
14 Jul 22
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
2yfdmsy rc9mfiieyss
14 Jul 22
Theratechnologies Reports Second Quarter and First Half
7:45am
6-K
EX-99.2
81sxk1ae 4u5p
13 Apr 22
Interim Consolidated Financial Statements
7:45am
6-K
EX-99.1
9l17t47q5dtz rgyb
13 Apr 22
Interim Consolidated Financial Statements
7:45am
6-K
EX-99.1
hozbrxfjfraa3yysb
13 Apr 22
Theratechnologies Reports Financial Results
7:30am
40-F
EX-99.1
gubwxs6 1y80mzs6ta
24 Feb 22
Annual report (Canada)
8:02am
40-F
EX-99.1
suaz4g8 6c
25 Feb 21
Annual report (Canada)
8:31am
40-F
EX-99.4
27vdarr z8umhggj
25 Feb 21
Annual report (Canada)
8:31am
40-F
EX-99.1
l0d e4buvd
25 Feb 20
Annual report (Canada)
8:11am
6-K
EX-99.1
6xaz8
19 Feb 20
Current report (foreign)
3:24pm
40FR12B
EX-99.1
6cy398ciuuw3kdcufbv
27 Sep 19
Initial registration of securities (Canada)
5:05pm
40FR12B
EX-99.38
xk9dj4 25u69t0we
27 Sep 19
Initial registration of securities (Canada)
5:05pm